Livebirth rates are influenced by an interaction between male and female partners’ age: analysis of 59 951 fresh IVF/ICSI cycles with and without male infertility

活产 不育 妇科 怀孕 生殖医学 胚胎移植 医学 自发受孕 产科 不明原因不孕症 后代 妊娠率 精子 子宫内膜异位症 男性不育 生物 男科 遗传学
作者
Adrija Kumar Datta,Stuart Campbell,R Diaz-Fernandez,G Nargund
出处
期刊:Human Reproduction [Oxford University Press]
标识
DOI:10.1093/humrep/deae198
摘要

Abstract STUDY QUESTION Does advanced male partner’s age impact live birth rates (LBRs) in IVF treatment when female partner’s age is factored in? SUMMARY ANSWER In fresh IVF cycles LBRs decline with male partner’s age ≥40 years when the female partner is aged 35–39 years, irrespective of the presence or absence of male factor; but not when the female partner is <35 years or ≥40 years of age; this decline is not observed in ICSI cycles. WHAT IS KNOWN ALREADY Advanced paternal age is associated with declining sperm parameters, impaired embryo development, compromised pregnancy outcomes, and abnormalities in the offspring in IVF/ICSI cycles. However, data on the interaction between maternal and paternal age on IVF outcomes are very limited and inconsistent. No significant effect of male partner’s age on pregnancy outcomes has been noted in donor oocyte cycles. STUDY DESIGN, SIZE, DURATION Retrospective analysis of all eligible autologous IVF/ICSI cycles with oocyte retrieval and intended fresh embryo transfer (ET) from the UK’s national anonymized registry, published online by the Human Fertilisation and Embryology Authority (HFEA). There were 59 951 cycles that qualified the inclusion criteria in the study period: 1 January 2017 to 31 December 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS Couples underwent IVF (n = 27 226) or ICSI (n = 32 725) treatment with partner’s sperm followed by fresh ET due to unexplained (n = 31 846), tubal (n = 6605), or male infertility (n = 22 905). Treatment cycles with endometriosis (n = 5563), ovulatory disorders (n = 9970), female partner aged >44 years (n = 636), and PGT (n = 280) were excluded. Women were stratified by age in the following groups: <35, 35–39, 40–42, and 43–44 years; male partner’s age as <35 (reference group), 35–37, 38–39, 40–42, 43–44, 45–50, 51–55, 55–60, and >55 years as presented by the HFEA. Some age-groups were merged in the analysis to increase the population size. Chi-square test was used to compare binominal data; and multiple logistic regression to find any association between male and female age-groups on live birth adjusting for other confounders that had a significant effect on this outcome. MAIN RESULTS AND THE ROLE OF CHANCE LBRs per oocyte retrieval as well as per ET were no different across the male partners’ age-groups when the female partners were aged <35 years or in 40- to 44-year age-group, whether male-factor infertility was included or excluded and whether it was IVF or ICSI cycle. However, when IVF was the method of insemination in the female partner’s age-group of 35–39 years, LBRs per oocyte retrieval dropped significantly from 27.0% in the male age-group of <35 years (reference group) to 22.9% (P = 0.002), 22.0% (P = 0.006), and 18.8% (P = 0.004) in 40–44, 45–50, and >50 years age-group, respectively in population that included male-factor infertility. Likewise, LBR per retrieval declined from 27.6% in 35 years age-group to 23.5% (P = 0.002) and 22.2% (P = 002) in 40–44 years and older groups, respectively in cycles without male infertility. However, there was no impact of male age on LBR in any female partner’s age-group when ICSI was performed in either the presence or the absence of male infertility. A similar decline in the LBR per retrieval and per ET was observed in female age-group of 35–39 years in the analyses with IVF and ICSI cycles combined. The inference remained unchanged when only the first treatment cycle was included (per patient analysis) or when single blastocyst transfer cycles were analysed, eliminating the impact of the number and stage of embryo transferred. After adjusting for confounders including male age, female age, number of previous treatment cycles, previous live birth, insemination method (IVF or ICSI), number of embryos transferred, and day (stage) of ET, male partner’s age remained significantly associated with LBR in the female age-group of 35–39 years, but not when women were in <35 years or 40- to 44-year age-group, in population including as well as excluding male infertility. Miscarriage rates per single ET trended to rise (non-significantly) in IVF as well as ICSI cycle only when men were over 55 years and female partners aged <40 years, particularly when male infertility was excluded. LIMITATIONS, REASONS FOR CAUTION Information on ovarian reserve and stimulation protocols was not available. This probably would have had little impact, given the large size of the population studied. The ages of female and male partners were given in groups necessitating taking them as ordinal variable in the regression analysis. Cumulative LBRs could not be determined as the information on subsequent frozen-thawed ET cycles could not be traced and the severity or cause of abnormal semen parameters were not present in the HFEA database. Some age-groups with small number of patients were merged to obtain a reliable result. WIDER IMPLICATIONS OF THE FINDINGS This is the largest clinical data to support the laboratory evidence of the ability of oocytes from young women to reverse the age-related deterioration of sperm quality. As the ageing oocytes lose this reparatory mechanism, the ageing sperm exert a detrimental effect on the LBR. The message of this study is important in counselling of patients and planning out treatment. Further research on interaction between male and female age will increase our understanding of this matter and help to establish whether ICSI procedure is more appropriate for older male partners even when there is no apparent semen abnormality. STUDY FUNDING/COMPETING INTEREST(S) No funding was required. There is no competing interest. TRIAL REGISTRATION NUMBER N/A (retrospective analysis).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞快的蛋应助明天不打烊采纳,获得30
刚刚
万能图书馆应助杆杆采纳,获得10
刚刚
高高很厉害完成签到,获得积分10
1秒前
1秒前
2秒前
2秒前
行走的车发布了新的文献求助10
2秒前
QXS发布了新的文献求助10
2秒前
梁钋瑞发布了新的文献求助10
3秒前
wannada发布了新的文献求助10
3秒前
3秒前
zcc发布了新的文献求助10
3秒前
whatever举报陈陈陈陈陈求助涉嫌违规
3秒前
在路上发布了新的文献求助10
3秒前
4秒前
4秒前
4秒前
5秒前
lihua完成签到,获得积分10
5秒前
制药小兵完成签到,获得积分10
5秒前
徐zihao发布了新的文献求助10
5秒前
桐桐应助小步采纳,获得10
5秒前
5秒前
猪8986发布了新的文献求助10
6秒前
香蕉觅云应助刻苦的高丽采纳,获得10
6秒前
激昂的航空应助LEGION采纳,获得20
6秒前
Foch完成签到,获得积分10
6秒前
王佳亮完成签到,获得积分10
7秒前
7秒前
rongyiming发布了新的文献求助10
7秒前
张大明发布了新的文献求助10
7秒前
8秒前
TingWang完成签到,获得积分10
8秒前
QXS完成签到,获得积分10
8秒前
8秒前
8秒前
9秒前
兮槿发布了新的文献求助10
9秒前
ding应助炙热的远侵采纳,获得10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6017040
求助须知:如何正确求助?哪些是违规求助? 7600720
关于积分的说明 16154591
捐赠科研通 5164894
什么是DOI,文献DOI怎么找? 2764769
邀请新用户注册赠送积分活动 1745863
关于科研通互助平台的介绍 1635068